Rowlands R, Meyer Sauteur P, Beeton M, The Escmid Study Group For Mycoplasma And Chlamydia Infections Esgmac
J Med Microbiol. 2024; 73(10).
PMID: 39475213
PMC: 11523975.
DOI: 10.1099/jmm.0.001910.
Pereyre S, Henin N, Dolzy A, Guiraud J, Laurier-Nadalie C, Gardette M
J Clin Microbiol. 2024; 62(7):e0022624.
PMID: 38832769
PMC: 11324033.
DOI: 10.1128/jcm.00226-24.
Sabat A, Durfee T, Baldwin S, Akkerboom V, Voss A, Friedrich A
Front Cell Infect Microbiol. 2024; 14:1368923.
PMID: 38694516
PMC: 11062135.
DOI: 10.3389/fcimb.2024.1368923.
Klose S, Legione A, Bushell R, Browning G, Vaz P
Microb Genom. 2024; 10(3).
PMID: 38546735
PMC: 11004492.
DOI: 10.1099/mgen.0.001227.
Leng M, Yang J, Zhou J
Front Pediatr. 2023; 11:1115009.
PMID: 36937963
PMC: 10017863.
DOI: 10.3389/fped.2023.1115009.
Genomic insights into antibiotic resistance and mobilome of lactic acid bacteria and bifidobacteria.
Rozman V, Mohar Lorbeg P, Treven P, Accetto T, Janezic S, Rupnik M
Life Sci Alliance. 2023; 6(4).
PMID: 36781180
PMC: 9930590.
DOI: 10.26508/lsa.202201637.
Impact of 16S rRNA Single Nucleotide Polymorphisms on Mycoplasma genitalium Organism Load with Doxycycline Treatment.
Chua T, Danielewski J, Bodiyabadu K, Bradshaw C, Machalek D, Garland S
Antimicrob Agents Chemother. 2022; 66(5):e0024322.
PMID: 35420491
PMC: 9112994.
DOI: 10.1128/aac.00243-22.
Integrating the Human and Animal Sides of Mycoplasmas Resistance to Antimicrobials.
Pereyre S, Tardy F
Antibiotics (Basel). 2021; 10(10).
PMID: 34680797
PMC: 8532757.
DOI: 10.3390/antibiotics10101216.
Efflux Might Participate in Decreased Susceptibility to Oxytetracycline in Contagious Agalactia-Causative spp.
Tatay-Dualde J, Prats-van der Ham M, Gaurivaud P, de la Fe C, Tardy F
Animals (Basel). 2021; 11(8).
PMID: 34438907
PMC: 8388784.
DOI: 10.3390/ani11082449.
Azithromycin and Doxycycline Resistance Profiles of U.S. Mycoplasma genitalium Strains and Their Association with Treatment Outcomes.
Wood G, Jensen N, Astete S, Jensen J, Kenny G, Khosropour C
J Clin Microbiol. 2021; 59(11):e0081921.
PMID: 34406799
PMC: 8525566.
DOI: 10.1128/JCM.00819-21.
Clinical Efficacy of Doxycycline for Treatment of Macrolide-Resistant Pneumonia in Children.
Lee H, Choi Y, Sohn Y, Kim Y, Han M, Yun K
Antibiotics (Basel). 2021; 10(2).
PMID: 33671151
PMC: 7921960.
DOI: 10.3390/antibiotics10020192.
Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children.
Yang H
Korean J Pediatr. 2019; 62(6):199-205.
PMID: 30999732
PMC: 6584239.
DOI: 10.3345/kjp.2018.07367.
Macrolide-resistant prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study.
Yin Y, Wang R, Zhuo C, Wang H, Wang M, Xie C
J Thorac Dis. 2017; 9(10):3774-3781.
PMID: 29268385
PMC: 5723809.
DOI: 10.21037/jtd.2017.09.75.
Mutations Associated with Decreased Susceptibility to Seven Antimicrobial Families in Field and Laboratory-Derived Mycoplasma bovis Strains.
Sulyok K, Kreizinger Z, Wehmann E, Lysnyansky I, Banyai K, Marton S
Antimicrob Agents Chemother. 2016; 61(2).
PMID: 27895010
PMC: 5278709.
DOI: 10.1128/AAC.01983-16.
The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial Ribosome.
Heidrich C, Mitova S, Schedlbauer A, Connell S, Fucini P, Steenbergen J
Antibiotics (Basel). 2016; 5(4).
PMID: 27669321
PMC: 5187513.
DOI: 10.3390/antibiotics5040032.
Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment.
Pereyre S, Goret J, Bebear C
Front Microbiol. 2016; 7:974.
PMID: 27446015
PMC: 4916212.
DOI: 10.3389/fmicb.2016.00974.
Mycoplasmas and Their Antibiotic Resistance: The Problems and Prospects in Controlling Infections.
Chernova O, Medvedeva E, Mouzykantov A, Baranova N, Chernov V
Acta Naturae. 2016; 8(2):24-34.
PMID: 27437137
PMC: 4947986.
Mycoplasma bovis: Mechanisms of Resistance and Trends in Antimicrobial Susceptibility.
Lysnyansky I, Ayling R
Front Microbiol. 2016; 7:595.
PMID: 27199926
PMC: 4846652.
DOI: 10.3389/fmicb.2016.00595.
Potential Molecular Targets for Narrow-Spectrum Agents to Combat Mycoplasma pneumoniae Infection and Disease.
Balish M, Distelhorst S
Front Microbiol. 2016; 7:205.
PMID: 26941728
PMC: 4766277.
DOI: 10.3389/fmicb.2016.00205.
16S rRNA gene mutations associated with decreased susceptibility to tetracycline in Mycoplasma bovis.
Amram E, Mikula I, Schnee C, Ayling R, Nicholas R, Rosales R
Antimicrob Agents Chemother. 2014; 59(2):796-802.
PMID: 25403668
PMC: 4335885.
DOI: 10.1128/AAC.03876-14.
